SciVision Biotech Inc. (TPE:1786)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
65.20
+0.20 (0.31%)
At close: Mar 27, 2026
Market Cap4.88B -45.0%
Revenue (ttm)886.62M +0.4%
Net Income162.34M -33.0%
EPS2.18 -34.0%
Shares Out74.83M
PE Ratio29.93
Forward PEn/a
Dividend3.25 (4.98%)
Ex-Dividend DateApr 29, 2026
Volume199,955
Average Volume308,564
Open64.70
Previous Close65.00
Day's Range64.50 - 65.30
52-Week Range62.90 - 125.50
Beta0.51
RSI36.86
Earnings DateMay 8, 2026

About SciVision Biotech

SciVision Biotech Inc. develops and manufactures medical-grade hyaluronic acid products in Taiwan. The company offers synovial fluid supplements, facial dermal implants, absorbable adhesion barriers, and intravesical instillation products. It also involved in international trade; wholesale of medical equipment and cosmetics; and provides management advisory services. SciVision Biotech Inc. was founded in 1990 and is based in Kaohsiung, Taiwan. [Read more]

Sector Healthcare
Founded 1990
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 1786
Full Company Profile

Financial Performance

In 2025, SciVision Biotech's revenue was 886.62 million, an increase of 0.37% compared to the previous year's 883.31 million. Earnings were 162.34 million, a decrease of -32.99%.

Financial Statements